Rong L - Search Results

1

Self-Assembly of Hybridized Peptide Nucleic Acid Amphiphiles.

Liu LH, Li ZY, Rong L, Qin SY, Lei Q, Cheng H, Zhou X, Zhuo RX, Zhang XZ. Liu LH, et al. Among authors: rong l. ACS Macro Lett. 2014 May 20;3(5):467-471. doi: 10.1021/mz5001916. Epub 2014 May 6. ACS Macro Lett. 2014. PMID: 35590784

2

Stepwise-acid-active multifunctional mesoporous silica nanoparticles for tumor-specific nucleus-targeted drug delivery.

Li ZY, Liu Y, Hu JJ, Xu Q, Liu LH, Jia HZ, Chen WH, Lei Q, Rong L, Zhang XZ. Li ZY, et al. Among authors: rong l. ACS Appl Mater Interfaces. 2014 Aug 27;6(16):14568-75. doi: 10.1021/am503846p. Epub 2014 Aug 18. ACS Appl Mater Interfaces. 2014. PMID: 25103086

3

Co-delivery of proapoptotic peptide and p53 DNA by reduction-sensitive polypeptides for cancer therapy.

Chen S, Rong L, Jia HZ, Qin SY, Zeng X, Zhuo RX, Zhang XZ. Chen S, et al. Among authors: rong l. Biomater Sci. 2015 May;3(5):753-63. doi: 10.1039/c5bm00046g. Epub 2015 Mar 17. Biomater Sci. 2015. PMID: 26222594

4

A surface charge-switchable and folate modified system for co-delivery of proapoptosis peptide and p53 plasmid in cancer therapy.

Chen S, Rong L, Lei Q, Cao PX, Qin SY, Zheng DW, Jia HZ, Zhu JY, Cheng SX, Zhuo RX, Zhang XZ. Chen S, et al. Among authors: rong l. Biomaterials. 2016 Jan;77:149-63. doi: 10.1016/j.biomaterials.2015.11.013. Epub 2015 Nov 10. Biomaterials. 2016. PMID: 26599622

5

Self-defensive nano-assemblies from camptothecin-based antitumor drugs.

Qin SY, Peng MY, Rong L, Li B, Wang SB, Cheng SX, Zhuo RX, Zhang XZ. Qin SY, et al. Among authors: rong l. Regen Biomater. 2015 Sep;2(3):159-66. doi: 10.1093/rb/rbv011. Epub 2015 Aug 10. Regen Biomater. 2015. PMID: 26816639 Free PMC article.

6

Drug self-delivery systems for cancer therapy.

Qin SY, Zhang AQ, Cheng SX, Rong L, Zhang XZ. Qin SY, et al. Among authors: rong l. Biomaterials. 2017 Jan;112:234-247. doi: 10.1016/j.biomaterials.2016.10.016. Epub 2016 Oct 13. Biomaterials. 2017. PMID: 27768976 Review.

7

Stimuli-Responsive "Cluster Bomb" for Programmed Tumor Therapy.

Lei Q, Wang SB, Hu JJ, Lin YX, Zhu CH, Rong L, Zhang XZ. Lei Q, et al. Among authors: rong l. ACS Nano. 2017 Jul 25;11(7):7201-7214. doi: 10.1021/acsnano.7b03088. Epub 2017 Jul 12. ACS Nano. 2017. PMID: 28686414

8

Engineering Living Bacteria for Cancer Therapy.

Rong L, Lei Q, Zhang XZ. Rong L, et al. ACS Appl Bio Mater. 2020 Dec 21;3(12):8136-8145. doi: 10.1021/acsabm.0c01286. Epub 2020 Nov 18. ACS Appl Bio Mater. 2020. PMID: 35019596

9

One-pot construction of functional mesoporous silica nanoparticles for the tumor-acidity-activated synergistic chemotherapy of glioblastoma.

Li ZY, Liu Y, Wang XQ, Liu LH, Hu JJ, Luo GF, Chen WH, Rong L, Zhang XZ. Li ZY, et al. Among authors: rong l. ACS Appl Mater Interfaces. 2013 Aug 28;5(16):7995-8001. doi: 10.1021/am402082d. Epub 2013 Aug 2. ACS Appl Mater Interfaces. 2013. PMID: 23869943

10

Theranostic GO-based nanohybrid for tumor induced imaging and potential combinational tumor therapy.

Qin SY, Feng J, Rong L, Jia HZ, Chen S, Liu XJ, Luo GF, Zhuo RX, Zhang XZ. Qin SY, et al. Among authors: rong l. Small. 2014 Feb 12;10(3):599-608. doi: 10.1002/smll.201301613. Epub 2013 Sep 3. Small. 2014. PMID: 24000121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,252 results

Search Page